{"id":181963,"date":"2020-04-11T14:49:35","date_gmt":"2020-04-11T14:49:35","guid":{"rendered":"https:\/\/bm.dev.synology.me\/?p=181963"},"modified":"2020-04-11T14:49:35","modified_gmt":"2020-04-11T14:49:35","slug":"lumea-la-un-pas-sa-fie-salvata-de-coronavirus-producatorul-american-gilead-are-primele-semne-pozitive-in-testarea-unui-vaccin-impotriva-coronavirusului","status":"publish","type":"post","link":"https:\/\/bm.dev.synology.me\/?p=181963","title":{"rendered":"Lumea la un pas s\u0103 fie salvat\u0103 de coronavirus: Produc\u0103torul american Gilead are primele semne pozitive \u00een testarea unui vaccin \u00eempotriva coronavirusului"},"content":{"rendered":"<p>\nCompania american\u0103 de biotehnologie Gilead Sciences, care cerceteaz\u0103, dezvolt\u0103 \u015fi comercializeaz\u0103 medicamente, a dezvoltat un medicament experimental pentru pacien\u0163ii cu infec\u0163ii severe cu Covid-19 care d\u0103 primele semene pozitive, scrie Bloomberg.<\/p>\n<p>\nStudiul clinic desf\u0103\u015furat pe pacien\u0163ii a ar\u0103tat c\u0103 dup\u0103 18 zile, starea de s\u0103n\u0103tate a 68% dintre pacien\u0163i s-a \u00eembun\u0103t\u0103\u0163it, 17 pacien\u0163i dintre cei 30 de pacien\u0163i care erau venila\u0163i mecanic s-au \u00eens\u0103n\u0103to\u015fit \u015fi nu au mai avut nevoie de ajutor pentru respira\u0163ie. Aproape jum\u0103tate din pacien\u0163ii trata\u0163i nu au mai avut nevoie de ajuto, \u00een timp ce 13%, dintre ace\u015ftia, au murit. Gradul de mortalitate cel mai mare s-a \u00eenregistrat \u00een r\u00e2ndul pacien\u0163ilor ventila\u0163i mecanic, aproximativ 18% dintre ei murind.<\/p>\n<p>\n\u201eNu putem trage concluzii definitive din aceste date, dar observa\u0163iile acestui grup de pacien\u0163i spitaliza\u0163i care au primit remdesivir ne dau o urm\u0103 de speran\u0163\u0103\u201d, a declarat Jonathan Grein, directorul epidemiologic al spitalului din Cedars-Sinai Medical Center din Los Angeles, \u00eentr-o comunicat al Gilead.<\/p>\n<p>\nMai multe studii clinice la scar\u0103 larg\u0103 sunt \u00een desf\u0103\u015furare pentru a evalua beneficiul medicamentului remdesivir pentru Covid-19, boala cauzat\u0103 de noul coronavirus care a infectat peste 1,65 milioane de oameni \u00een \u00eentreaga lume \u015fi a ucis 100.000. Unul dintre studii, care a fost realizat \u00een China ar putea raporta rezultatele \u00een aceast\u0103 lun\u0103.<\/p>\n<p>\nGilead Sciences, Inc., este o companie american\u0103 de biotehnologie care cerceteaz\u0103, dezvolt\u0103 \u015fi comercializeaz\u0103 medicamente. Compania se concentreaz\u0103 \u00een principal pe medicamente antivirale utilizate \u00een tratamentul HIV, hepatitei B, hepatitei C \u015fi gripei, inclusiv Harvoni \u015fi Sovaldi.<\/p>\n<p>\n&nbsp;<\/p>\n<p>\n&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Compania american\u0103 de biotehnologie Gilead Sciences, care cerceteaz\u0103, dezvolt\u0103 \u015fi comercializeaz\u0103 medicamente, a dezvoltat un medicament experimental pentru pacien\u0163ii cu infec\u0163ii severe cu Covid-19 care d\u0103 primele semene pozitive, scrie Bloomberg. Studiul clinic desf\u0103\u015furat pe pacien\u0163ii a ar\u0103tat c\u0103 dup\u0103 18 zile, starea de s\u0103n\u0103tate a 68% dintre pacien\u0163i s-a \u00eembun\u0103t\u0103\u0163it, 17 pacien\u0163i dintre cei [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[12870,408,297,10923,97,14930],"class_list":["post-181963","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-american","tag-pacienti","tag-producator","tag-salvare","tag-testare","tag-vaccin"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/181963","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=181963"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/181963\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=181963"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=181963"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=181963"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}